Robin L. Washington

2011

In 2011, Robin L. Washington earned a total compensation of $4M as Executive Vice President and Chief Financial Officer at Gilead Sciences, a 22% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$555,210
Option Awards$1,259,911
Salary$615,175
Stock Awards$1,596,897
Other$5,000
Total$4,032,193

Washington received $1.6M in stock awards, accounting for 40% of the total pay in 2011.

Washington also received $555.2K in non-equity incentive plan, $1.3M in option awards, $615.2K in salary and $5K in other compensation.

Rankings

In 2011, Robin L. Washington's compensation ranked 1,431st out of 10,747 executives tracked by ExecPay. In other words, Washington earned more than 86.7% of executives.

ClassificationRankingPercentile
All
1,431
out of 10,747
87th
Division
Manufacturing
534
out of 3,960
87th
Major group
Chemicals And Allied Products
115
out of 1,033
89th
Industry group
Drugs
65
out of 781
92nd
Industry
Biological Products, Except Diagnostic Substances
8
out of 157
95th
Source: SEC filing on March 24, 2014.

Washington's colleagues

We found four more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2011.

2011

John Martin

Gilead Sciences

Chief Executive Officer

2011

John Milligan

Gilead Sciences

Chief Operating Officer

2011

Norbert Bischofberger

Gilead Sciences

Chief Scientific Officer

2011

Kevin Young

Gilead Sciences

Former Executive Vice President, Commercial Operations

News

You may also like